Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.31 |
| ▸ | BRD7 | Q9NPI1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20165781 | 0.80 | BRD9 (0.35) | MEN1KMT2ABRD9BRD7 | |
| SCHEMBL19393460 | 0.79 | LMNA (0.33) | — | |
| SCHEMBL15808729 | 0.79 | PTAFR (0.39) | — | |
| SCHEMBL2972383 | 0.72 | — | — | |
| SCHEMBL31355504 | 0.72 | BRD9 (0.33) | MEN1KMT2ABRD9BRD7 | |
| SCHEMBL31355503 | 0.72 | BRD9 (0.33) | MEN1KMT2ABRD9BRD7 | |
| SCHEMBL15809151 | 0.72 | KDM4E (0.32) | — | |
| SCHEMBL2481681 | 0.70 | CYP2A6 (0.37) | MEN1KMT2A | |
| SCHEMBL2971639 | 0.70 | ALDH1A1 (0.33) | — | |
| SCHEMBL28314871 | 0.69 | BRD9 (0.34) | MEN1KMT2ABRD9BRD7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11981801-B2 | Polypropylene composition | BOREALIS AG (AT) | 2024-05-14 | — | — | US | disclosed |
| US-20230242748-A1 | POLYPROPYLENE COMPOSITION | BOREALIS AG (AT) | 2023-08-03 | — | — | US | disclosed |
| CN-110770264-B | Process for preparing heterophasic propylene copolymers | 博里利斯股份公司 | 2022-10-14 | — | — | CN | disclosed |
| CN-110177798-B | Catalyst and process for preparing same | 博里利斯股份公司 | 2022-08-30 | — | — | CN | disclosed |
| US-11352376-B2 | Catalysts | BOREALIS AG (AT) | 2022-06-07 | — | — | US | disclosed |
| CN-110741039-B | Polypropylene composition | 博里利斯股份公司 | 2022-02-18 | — | — | CN | disclosed |
| US-11078304-B2 | Process for preparing heterophasic propylene copolymers | BOREALIS AG (AT) | 2021-08-03 | — | — | US | disclosed |
| EP-3541823-B1 | CATALYSTS | BOREALIS AG (AT) | 2020-12-30 | — | — | EP | disclosed |
| EP-3652247-A1 | POLYPROPYLENE COMPOSITION | Borealis AG (AT) | 2020-05-20 | — | — | EP | disclosed |
| US-20200131284-A1 | PROCESS FOR THE PREPARING HETEROPHASIC PROPYLENE COPOLYMERS | BOREALIS AG (AT) | 2020-04-30 | — | — | US | disclosed |
| CN-110770264-A | Process for preparing heterophasic propylene copolymers | 博里利斯股份公司 | 2020-02-07 | — | — | CN | disclosed |
| CN-110741039-A | Polypropylene composition | 博里利斯股份公司 | 2020-01-31 | — | — | CN | disclosed |
| US-20190308995-A1 | CATALYSTS | BOREALIS AG (AT) | 2019-10-10 | — | — | US | disclosed |
| EP-3541823-A1 | CATALYSTS | Borealis AG (AT) | 2019-09-25 | — | — | EP | disclosed |
| CN-110177798-A | Catalyst | 博里利斯股份公司 | 2019-08-27 | — | — | CN | disclosed |
| WO-2019012110-A1 | POLYPROPYLENE COMPOSITION | BOREALIS AG (AT) | 2019-01-17 | — | — | WO | disclosed |
| WO-2018091684-A1 | CATALYSTS | BOREALIS AG (AT) | 2018-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352376-B2 | Catalysts | SIGMAR1, H1-2, SFN | MEN1 1490/4885KMT2A 473/4885BRD9 1797/4885 |
| US-20190308995-A1 | CATALYSTS | SIGMAR1, H1-2, CBR1 | MEN1 1642/4885KMT2A 406/4885BRD9 1700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.